Prostate Specific Antigen News and Research

RSS
Axumin approved for use in PET scans in patients with recurrent prostate cancer

Axumin approved for use in PET scans in patients with recurrent prostate cancer

New IsoPSA test identifies molecular structural changes in protein biomarkers to detect prostate cancer

New IsoPSA test identifies molecular structural changes in protein biomarkers to detect prostate cancer

New model can increase active surveillance for low-risk prostate cancer patients

New model can increase active surveillance for low-risk prostate cancer patients

CWRU scientists develop computational tools to quantify effects of prostate cancer laser ablation

CWRU scientists develop computational tools to quantify effects of prostate cancer laser ablation

Study assesses risk factors for metastases in prostate cancer patients on active surveillance

Study assesses risk factors for metastases in prostate cancer patients on active surveillance

Experimental urine test identifies 92% of men with elevated PSA levels

Experimental urine test identifies 92% of men with elevated PSA levels

Scientists provide overview of most promising compounds to combat prostate cancer

Scientists provide overview of most promising compounds to combat prostate cancer

ANGLE’s Parsortix system may be used for detection of prostate cancer, Barts patient data suggests

ANGLE’s Parsortix system may be used for detection of prostate cancer, Barts patient data suggests

ZYTIGA plus prednisone provides overall survival benefit in men with early and less aggressive mCRPC

ZYTIGA plus prednisone provides overall survival benefit in men with early and less aggressive mCRPC

CWRU researcher to customize tobacco mosaic virus to treat human cancers

CWRU researcher to customize tobacco mosaic virus to treat human cancers

Active surveillance recommended for low-risk prostate cancer

Active surveillance recommended for low-risk prostate cancer

ASTRO's new research journal 'Advances in Radiation Oncology' closes first issue

ASTRO's new research journal 'Advances in Radiation Oncology' closes first issue

New biosensor test system developed for accurate measurements of protein molecule concentration in blood

New biosensor test system developed for accurate measurements of protein molecule concentration in blood

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy

Men not having important discussions with health providers about prostate cancer screening, treatment

Men not having important discussions with health providers about prostate cancer screening, treatment

Study supports argument that declining PSA screening may lead to avoidable cancer deaths

Study supports argument that declining PSA screening may lead to avoidable cancer deaths

African American men with prostate cancer have significantly lower PSA density than Caucasian men

African American men with prostate cancer have significantly lower PSA density than Caucasian men

Repeating abnormal PSA tests can reduce unnecessary biopsies

Repeating abnormal PSA tests can reduce unnecessary biopsies

Two studies find decline in PSA screening and prostate cancer incidence

Two studies find decline in PSA screening and prostate cancer incidence

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.